A detailed history of Aqr Capital Management LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 194,663 shares of TVTX stock, worth $3.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
194,663
Previous 74,069 162.81%
Holding current value
$3.34 Million
Previous $608,000 347.86%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.89 - $15.21 $951,486 - $1.83 Million
120,594 Added 162.81%
194,663 $2.72 Million
Q2 2024

Aug 14, 2024

BUY
$5.26 - $8.28 $139,311 - $219,295
26,485 Added 55.66%
74,069 $608,000
Q1 2024

May 15, 2024

BUY
$7.18 - $9.82 $218,279 - $298,537
30,401 Added 176.92%
47,584 $366,000
Q4 2023

Feb 14, 2024

SELL
$5.44 - $9.5 $169,009 - $295,146
-31,068 Reduced 64.39%
17,183 $154,000
Q3 2023

Nov 14, 2023

BUY
$7.64 - $17.25 $368,637 - $832,329
48,251 New
48,251 $431,000
Q1 2023

May 15, 2023

SELL
$17.82 - $22.89 $149,474 - $192,001
-8,388 Reduced 45.87%
9,898 $222,000
Q4 2022

Feb 14, 2023

SELL
$18.47 - $26.14 $234,402 - $331,742
-12,691 Reduced 40.97%
18,286 $384,000
Q3 2022

Nov 14, 2022

BUY
$22.91 - $28.63 $144,493 - $180,569
6,307 Added 25.57%
30,977 $763,000
Q2 2022

Aug 15, 2022

SELL
$20.94 - $30.01 $811,487 - $1.16 Million
-38,753 Reduced 61.1%
24,670 $598,000
Q1 2022

May 16, 2022

SELL
$23.61 - $30.6 $278,503 - $360,957
-11,796 Reduced 15.68%
63,423 $1.63 Million
Q4 2021

Feb 14, 2022

BUY
$24.34 - $31.17 $254,523 - $325,944
10,457 Added 16.15%
75,219 $2.34 Million
Q3 2021

Nov 15, 2021

SELL
$12.98 - $25.03 $207,290 - $399,729
-15,970 Reduced 19.78%
64,762 $1.57 Million
Q2 2021

Aug 16, 2021

BUY
$14.11 - $26.4 $492,876 - $922,178
34,931 Added 76.27%
80,732 $1.18 Million
Q1 2021

May 17, 2021

BUY
$23.37 - $31.77 $372,611 - $506,540
15,944 Added 53.4%
45,801 $1.14 Million
Q4 2020

Feb 16, 2021

BUY
$19.17 - $27.87 $572,358 - $832,114
29,857 New
29,857 $814,000

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.1B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.